Emerald Investment Advisers LLC Invests $1.81 Million in CVS Health Corporation $CVS

Key Points

• Emerald Investment Advisers acquired a new $1.81 million stake in CVS Health during the second quarter, purchasing 17,468 shares. Institutional investors and hedge funds collectively own 80.66% of CVS stock.
• CVS reported quarterly EPS of $2.58, exceeding the $1.87 analyst consensus, while revenue rose 7.3% year over year to $106.1 billion. The company maintained fiscal 2026 EPS guidance of $7.90–$8.10.
• Analysts maintain a generally positive outlook, with 22 Buy ratings and two Holds, an average “Moderate Buy” rating, and a consensus price target of $107.17 versus the reported share price of $93.01. CVS also offers a $0.665 quarterly dividend, yielding approximately 2.9%.

Emerald Investment Advisers LLC acquired a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 17,468 shares of the pharmacy operator's stock, valued at approximately $1,807,000.

A number of other large investors have also modified their holdings of CVS. Sei Investments Co. boosted its position in shares of CVS Health by 17.4% during the 2nd quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator's stock valued at $62,474,000 after acquiring an additional 134,535 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in CVS Health by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator's stock worth $77,353,000 after purchasing an additional 13,329 shares during the period. Treasurer of the State of North Carolina boosted its holdings in CVS Health by 1.3% during the second quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator's stock valued at $40,358,000 after purchasing an additional 7,588 shares in the last quarter. HUB Investment Partners LLC grew its stake in shares of CVS Health by 25.0% in the 2nd quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator's stock valued at $1,039,000 after purchasing an additional 3,011 shares during the period. Finally, Alliancebernstein L.P. raised its holdings in shares of CVS Health by 8.0% in the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator's stock worth $111,017,000 after buying an additional 119,439 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

CVS Health stock opened at $93.01 on Friday. The stock has a 50-day simple moving average of $102.02 and a 200 day simple moving average of $88.86. The stock has a market capitalization of $118.96 billion, a price-to-earnings ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company's revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's dividend payout ratio is 70.37%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent analyst reports. Wall Street Zen raised CVS Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 8th. Morgan Stanley lifted their price objective on CVS Health from $106.00 to $111.00 and gave the company an "overweight" rating in a report on Thursday, June 4th. Mizuho boosted their target price on shares of CVS Health from $110.00 to $115.00 and gave the company an "outperform" rating in a research note on Monday, June 8th. Piper Sandler reaffirmed an "overweight" rating and issued a $113.00 target price on shares of CVS Health in a report on Monday, June 1st. Finally, Royal Bank Of Canada increased their target price on shares of CVS Health from $107.00 to $113.00 and gave the stock an "outperform" rating in a research report on Thursday, July 9th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and an average price target of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source